Immune Tolerance Network

OrganisationROR

Trials

NCT04502966
Collaborator, Phase 2, Completed, 199 people, 6 Aug 2020
NCT03654040
Collaborator, Phase 1/2, Terminated, 42 people, 31 Aug 2018
NCT03577431
Collaborator, Phase 1/2, Completed, 9 people, 5 Jul 2018
NCT03504241
Collaborator, Phase 1, Completed, 8 people, 20 Apr 2018
NCT02293837
Collaborator, Phase 2, Completed, 136 people, 18 Nov 2014
NCT02260934
Collaborator, Phase 2, Completed, 43 people, 9 Oct 2014
NCT02029638
Collaborator, Phase 2, Terminated, 4 people, 8 Jan 2014
NCT01335139
Collaborator, Phase 2, Completed, 106 people, 14 Apr 2011
NCT01318915
Collaborator, Early phase 1, Terminated, 10 people, 21 Mar 2011
NCT00801632
Collaborator, Phase 2, Completed, 5 people, 3 Dec 2008
NCT00774852
Collaborator, Phase 2, Completed, 137 people, 17 Oct 2008
NCT00525889
Collaborator, Phase 1, Completed, 9 people, 6 Sept 2007
NCT00346151
Collaborator, Phase 2, Terminated, 5 people, 29 Jun 2006
NCT00288626
Collaborator, Phase 2, Completed, 25 people, 8 Feb 2006
NCT00183248
Collaborator, Phase 1/2, Completed, 9 people, 16 Sept 2005
NCT00166556
Collaborator, Phase 2, Completed, 10 people, 14 Sept 2005
NCT00135694
Collaborator, Phase 2, Completed, 275 people, 26 Aug 2005
NCT00129259
Collaborator, Phase 2, Completed, 83 people, 11 Aug 2005
NCT00105235
Collaborator, Phase 2, Completed, 27 people, 11 Mar 2005
NCT00104299
Collaborator, Phase 2/3, Completed, 197 people, 25 Feb 2005